There's a growing momentum to legalize therapeutic psychedelics in the United States, with clinics nationwide already offering ketamine therapy, as well as the recent decriminalization of psilocybin in Oregon. What do today's treatment protocols look like, and what will the future bring? In this episode, Yaron Conforti, CEO and Director of Novamind, talks with Paul Austin, founder of Third Wave, about creating individualized treatment plans, the thousands of clinics we can expect in the next ten years, and democratizing access to psychedelic medicine.